Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2003
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1140917B1 S-oxide lipid lowering compounds
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0991649B1 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0783496B1 Thiazolidinedione derivatives, their production and use
03/26/2003EP0606248B1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
03/26/2003CN1406237A Novel benzosultam oxazolidinone antibacterial agents
03/26/2003CN1406231A Pyrimidine compounds
03/26/2003CN1406230A 2,4-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
03/26/2003CN1406229A Pyrimidine compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405162A C7 ester-substituted taxane
03/26/2003CN1103772C Novel 2,3-disubstituted-4 (3H)-quinazolinone
03/26/2003CN1103770C Quino xaline diones
03/26/2003CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM
03/26/2003CA2423902A1 Benzodiazepine derivative
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538013 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
03/25/2003US6537988 Synergistic methods and compositions for treating cancer
03/25/2003US6537987 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
03/25/2003US6537986 Oxazolidinone antibacterial agents having a thiocarbonyl funtionality
03/25/2003US6537948 Uracil compounds and use thereof
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/20/2003WO2003022844A2 Synthesis of epothilones intermediates thereto and analogues thereof
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022269A1 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002030886A3 Heterocyclic angiogenesis inhibitors
03/20/2003US20030055263 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055085 For therapy of stroke, head trauma, anoxic injury, ischemic injury, hypoglycemia, epilepsy, pain, migraine headaches, Parkinson's disease, senile dementia, Huntington's Chorea, anxiety, and Alzheimer's disease
03/20/2003US20030055079 For therapy and prophylaxis of metabolic disorders related to insulin resistance or hyperglycemia typically associated with obesity or glucose intolerance
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055065 Administering tricyclic amide and urea compounds for inhibiting the abnormal growth of cells
03/20/2003US20030055064 Piperazine compounds and medicinal use thereof
03/20/2003US20030055062 Heteroaryl urea neuropeptide Y Y5 receptor antagonists
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055051 Having anti- inflammatory effect, which is less irritant, which has high safety and storage stability
03/20/2003US20030055049 For therapy of abnormal cell growth, such as cancer, in mammals
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055034 Preparing a concentrated inhalable aztreonam formulation comprising aztreonam dissolved in an aerosolable solution; delivering aztreonam dry powder or the aerosolable solution to the lung endobronchial space of airways of a patient
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003CA2458628A1 Use of substituted aminomethyl chromans in the treatment of movement disorders
03/19/2003EP1293503A1 Triazole derivatives
03/19/2003EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
03/19/2003EP1292595A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
03/19/2003EP1292594A1 Quinazoline derivatives for the treatment of tumours
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292585A1 Benzoxazepinones and their use as squalene synthase inhibitors
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292310A1 Novel anti-infectives
03/19/2003EP1114047B1 An improved process for the preparation of thiazolidine-2,4-dione derivatives
03/19/2003EP0768879B1 Thiadiazole compounds as d3 dopamine receptor ligands
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1103338C Heterocyclic compound for treating myocardial ischaemia
03/19/2003CN1103336C Process for producing unsymmetrical 4,6-bis (aryloxy) pyrimidine compound
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534531 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003CA2217351C Carbonyl-piperazinyl and piperidinyl compounds which inhibit farnesyl protein transferase
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021228A2 Heteroaryl substituted benzothiazole dioxetanes
03/13/2003WO2003020719A1 1,3-benzothiazinone derivatives and use thereof
03/13/2003WO2003020712A1 Oxadiazolyl-phenoxyalkylthiadiazoles, compositions thereof and methods for their use as anti-picornaviral agents
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
03/13/2003WO2003020710A1 Benzothiazepine derivatives
1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 628